CD34 and acute myeloid leukemia: The aim of this present study was to characterize the molecular consequences of AML transformation by comparing primary AML cells with normal CD34+ bone marrow cells, i.e., a normal counterpart for this bone marrow malignancy that also shows limited differentiation [10,11,12,13,14,15].